Project Grant R37DA063274
Award Date
8/1/25
Completion Date
4/30/30
Dollars Obligated
$787K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a $2,437,310 project at the University of California, San Diego (UCSD) to prospectively study the intersection between substance use, HIV, and related comorbidities in a binational cohort of people who inject drugs (PWID) in San Diego County. The 5-year project aims to track emerging substance use trends and evaluate the impact of harm...
This Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), represents a $2,310,463.14 effort to establish the PRIDE-CARES Center. The center aims to address gaps in substance use disorder (SUD) research and treatment for the sexual and gender minority (SGM) community. Key objectives include creating a Virtual Patient Engagement Panel to actively engage patients and stakeholders in SUD research, conducting a...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,756,612 to the University of California, Los Angeles (UCLA) to conduct research on the impacts of racial inequality on substance use and HIV outcomes among sexual minority men of color in Los Angeles County. The key products and services to be delivered under this 5-year award include: 1) investigating how historical racist practices influence...
The National Institute on Drug Abuse (NIDA) awarded a $687,416 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, CA. The grant supports research to develop therapeutically effective latency-promoting agents (LPAs) that can "block" HIV reactivation and "lock" HIV in a silenced state, even in the presence of addictive substances, for people living...
This $3,096,164 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to evaluate the efficacy and implementation of a peer-led Motivational Interviewing (MI) intervention called MI-CHANCE. The intervention aims to promote uptake of drug checking services (DCS) and safer drug use behaviors among people who use drugs (PWUD) in San Diego County to reduce overdose incidence. The 5-year study will...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop effective methods for disseminating scientific evidence to policymakers in order to improve access to services that can prevent HIV transmission and overdose among people who use drugs. The $2,362,500 award, effective July 1, 2025 through June 30, 2029, will be administered by the University of California, Los Angeles...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and assessment of a behavioral economic intervention to improve HIV-related behaviors among sexual minority men (SMM). The $264,091 award, effective September 15, 2024, aims to refine and evaluate the feasibility and acceptability of an Episodic Future Thinking (EFT) intervention delivered via smartphone to address delayed...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,223,769 to the University of California, San Diego (UCSD) to conduct research on the intertwined mechanisms of HIV and opioid use on mitochondrial-mediated inflammasome activation and neurotoxicity. The research aims to elucidate how the convergence of HIV infection and opioid use leads to more severe neurological consequences, including...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), is funding research at the University of California, San Diego (UCSD) to comprehensively evaluate the relationship between trauma exposure and substance use among Americans from childhood through adulthood. The $158,246 award, effective July 1, 2025 through June 30, 2027, will support the investigation of how situational stress factors moderate...